* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Symbiotic Viruses of Eukaryots - Initial Set Up
Survey
Document related concepts
Transcript
Symbiotic Viruses of Eukaryotes Brett Hoffman [email protected] Program in Vaccinology and Immunotherapeutics School of Public Health and Vaccine and Infectious Disease Organization University of Saskatchewan Canada For: Advanced Virology (VTMC833) © Brett Hoffman Abstract Introduction Polydnavirus Background PDV genes PDV evolution Endogenous retroviruses Background Receptor interference Postentry blocks Roles in host physiology Other Symbiotic viruses Concluding Remarks References Abstract There is a growing body of research that suggests numerous eukaryotic viral infections have beneficial effects on their hosts. This is in contrast to the view of viruses as obligate 1 intracellular pathogens. While this view may hold true for the vast majority of viruses of eukaryotes there are a number that should be considered intracellular symbionts. Polydnaviruses (PDVs) represent an example of these symbiotic viruses. PDVs are produced in multiple parasitic wasp species and are injected along with eggs during oviposition into a lepidopteran host. Within the lepidopteran host viral gene expression results in the suppression of the immune response which is necessary for the survival of the parasitoid offspring. Another group of symbiotic viruses are classified as endogenous retroviruses (ERVs). Numerous ERVs have been found in several eukaryotic species that contain open reading frames which express proteins capable of interfering with exogenous retroviral infection either by blocking entry through receptor interference or blocking steps further along in the retroviral lifecycle. There is also increasing evidence to suggest that ERVs may play important roles in host physiology. In sheep ERV encoded envelope glycoproteins have been found to be essential in the process of placenta morphogenesis. This finding adds further support for a role of ERV derived syncytins in this process within humans. Other viral infections that are proposed to have beneficial impacts on their hosts include latent herpes virus infections. These latent infections may provide protection against pathogens such as Listeria monocytogenes by maintaining the innate immune system in a heighted state of activation as well as reducing the development of allergies. Two common themes emerge when investigating the mechanisms through which these symbiotic viruses benefit the host, lateral gene transfer via integration that provides the host with new genetic material encoding for novel functions and the modulation of the immune system by such symbiotic viruses. 2 Introduction Viruses are typically described as being obligate intracellular pathogens which implies that all viruses are pathogens and therefore have negative or at best benign impacts on the organisms which they infect. This is true in almost all cases as some of the most destructive and deadly diseases of eukaryotes are caused by viral infections. Examples include the devastating hemorrhagic fever caused by Ebola virus as well as smallpox caused by Variola virus which is believed to have killed millions of people until its eradication in the 1980’s [58]. However, there are examples emerging of viruses that have beneficial effects on there hosts, playing key roles in their resistance to pathogens and perhaps even essential roles in host physiology. This suggests that such viruses may have had beneficial impacts on the evolution of the host species. The idea of viral symbiosis playing a key role in host evolution was popularized by Lynn Margulis [43]. She proposed that symbiotic relationships are the driving force of evolution and this is evident in the widely accepted endosymbiotic theory which describes the acquisition of the chloroplast and mitochondria by the ancestral eukaryotic cells from bacteria [20, 43]. This review will focus on examples of symbiotic viruses and will discuss such examples as the polydnaviruses (PDVs) of parasitic wasps which are crucial for the suppression of the immune responses in the lepidopteran larvae in which the wasp offspring develops [28]. Other topics to be discussed include the roles of endogenous retroviruses in protecting their hosts from exogenous retroviral infection as well as possible roles in host physiology. The possibility of some viruses, such as latent herpes virus, to act as symbionts through modulation of immune responses will also be discussed [6, 52]. 3 Polydnavirus Figure 1: General parasitoid wasp lifecycle and the role and characteristics of Polydnavirus. A) Life cycle of parasitoid wasps and PDV. (1) Female wasp oviposits single or multiple eggs along with numerous PDV particles into lepidopteran larval host. The PDV genome is also present as integrated provirus within genome of parasitoid egg. (2) PDVs invade multiple tissues within lepidopteran host such as hemocytes and fat body cells where viral gene expression occurs. Viral gene products suppress the lepidopteran immune responses permitting the survival of the parasitoid egg which hatches releasing larva that begin to feed and develop. (3) While lepidopteran immune responses remain suppressed by PDV gene products parasitoid larva complete juvenile development and emerge from lepidopteran host. The mature larva forms a cocoon on surface of host and undergoes pupation. During pupation the integrated PDV present in wasp genome is replicated, excised and viral particles 4 are formed in the calyx cells of developing female wasps. (4) Adult wasp emerges and lepidopteran host dies. PDV particles continue to be produce to high numbers in calyx cells of adult female wasp. Figure adapted from references [68, 69]. Background Polydnaviruses (PDVs) are atypical viruses that are found in numerous endoparasitic hymenoptera (parasitoid wasp) species and are essential to the lifecycle of these wasps [20. 73]. PDVs are thus referred to as obligate symbiotic viruses [20]. There are at least 30,000 species of parasitoid wasps harboring PDVs [71]. The polydnavirus genome that is found within virus particles is unique in that it is composed of a series of circular double stranded DNA molecules that vary in size from 4kb to 41.5kb [73]. In addition to being found within viral particles the polydnavirus genome also exists as a stable linear provirus molecule that is integrated within the parasitoid genome [72]. This provirus is vertically transmitted by female wasps to their offspring in a typical Mendelian fashion [25, 72]. These viruses are not known to cause any pathology in the parasitoid wasps [72]. Each PDV from a given wasp species is genetically unique but all PDVs share a similar lifecycle (Figure 1) [73]. Virus replication occurs exclusively in the calyx cells of the female wasp ovary where the integrated copies of the segmented viral genome are excised, circularized, replicated and packaged [38]. The exact mechanism by which PDV genome replication occurs is still unknown. However, it is thought that replication may occur by a rolling‐circle type mechanism in which the excision of proviral DNA is followed by amplification of circular episomes [36]. An alternative model proposed suggests that larger chromosome regions are amplified prior to the excision of individual viral segments for 5 packaging [36]. Once virus replication and packaging is complete, virus particles are released into the lumen of the oviduct and are subsequently injected along with the parasitoid egg into a lepidopteran larval host during oviposition [38]. Within the lepidopteran host the PDV infects multiple tissues, such as hemocytes and fat body cells. Viral genes are then expressed by cellular machinery leading to the suppression of the lepidopteran immune response as well as disrupting the development of the lepidopteran host [61]. With the immune response suppressed the parasitoid egg/larvae is able to successfully develop within the haemocoele of the lepidopteran host [72]. Upon completion of larval development the mature larva will emerge out from the parasitized host, spin a cocoon, pupate and emerge as adults [72]. This process results in the death of the lepidopteran larval host [72]. Unlike a typical virus infection, PDVs do not produce a replicative infection within the lepidopteran host [28]. Only viral gene expression occurs in this host while no viral replication or particle assembly takes place [28]. Therefore the virus is only propagated by its passage from female wasp to offspring via integration within the wasp genome [71]. The primary immune response inhibited by PDVs is the encapsulation of the injected parasitoid eggs by hemocytes within the lepidopteran host [69]. Multiple classes of hemocytes, with granulocytes and plasmocytes being the most abundant, are involved in phagocytosis of small particles and the encapsulation of larger objects [30]. Granulocytes are thought to recognize foreign surfaces and release cytokines that recruit plasmocytes to the surface of the foreign object, in this case the parasitoid egg [59, 64]. The plasmocytes then bind, surround and encapsulate the foreign object [30]. This process typically results in the destruction of the encapsulated object but the mechanism of destruction is unknown 6 [30]. It has been shown that active PDVs are required to inhibit this response [20]. When parasitoid eggs were artificially injected without the PDV or with UV inactivated PDV the eggs were destroyed via the encapsulation response [20]. PDVs belong to the Polydnaviridae family of viruses and are further divided into two phylogenetically unrelated genera, Bracovirus (BV) and Ichnovirus (IV) that are associated with braconid or ichneumonid parasitoid wasps respectively [35,74]. PDVs from these two genera differ in several aspects other than host range including morphology and morphogenesis as well as envelope structure [38]. The Bracovirus PDV nucleocapsid is cylindrical whereas the Ichnovirus PDVs poses a lenticular nucleocapsid, and in both genera each nucleocapsid is thought to contain only one of the multiple circular dsDNA segments [7, 9, 38]. Single or multiple Bracovirus nucleocapsids are surrounded by a single envelope membrane and these virus particles are released into the lumen of the oviduct by lysis of the calyx epithelial cells in which they are produced [7,38]. Cell lysis does not cause host pathology as these cells are continuously renewed [18]. By contrast Ichnovirus nucleocapsids are typically surrounded individually by a double layer envelope membrane and are released from the calyx cells by exocytosis [38]. An example of a Bracovirus is Cotesia plutellae bracovirus (CpBV) of C.plutellae which parasitizes the diamond back moth (Plutella xylostella) (Figure 1B) [35]. The genome of CpBV is estimated to be 470kb in size, made up of at least 27 non‐redundant segments ranging in size from 6 to37kb [35]. An example of an Ichnovirus is Campoletis sonorensis ichnovirus (CsIV) of C. sonorensis that parasitizes the tobacco budworm (Heliothis viresccens) (Figure 1C) [22]. The genome of CsIV is approximately 248kb in size divided into 24 unique dsDNA segments that range in size from 6.1kb to 19.5kb [22]. 7 Figure 1B. Characteristics of Cotesia plutellae Bracovirus, a polydnavirus belonging to the Bracovirus genera [35]. 8 Figure 1C Characteristics of Campoletis sonorensis Ichnovirus, a polydnavirus belonging to the Ichnovirus genera [22]. PDV Genes PDV genes share a number of features that are typical of eukaryotic genes rather than viral genes, such as low coding density (29% for CsIV), the presence of introns and homology with other eukaryotic genes [9,36]. The packaged genome of PDV also completely lacks genes encoding for viral structural proteins or proteins required for virus replication [16]. The genes of various PDVs are organized into gene families based on sequence homology and not all gene families are found in each species [36, 71]. The following is a brief review of some of the better characterized and conserved gene families 9 of PDVs (Table 1). This is by no means a complete list of the numerous PDV gene families and it should be noted that there have been many PDV genes identified that share no known homology and have unknown function [28]. For a more comprehensive review of PDV gene families please refer to the article by Kroemer et al. [36]. Table 1. Polydnavirus gene families PDV genes Cys gene family Example: VHv1.1 of CsIV PTP gene family Example: ptp‐H2 of MdBV C‐type lectin gene family Example: CpBV‐lectin Rep gene family Vinnexin gene family Viral Histone H4 genes Function Linked to suppression of host cellular immunity Interferes with encapsulation response and disrupts host larval growth and development Linked to both up and down regulation of intracellular signaling Inhibits phagocytosis by granulocytes/plasmocytes and induces apoptosis in these cells Pattern recognition molecules that 'mask' molecular patterns from host c‐type lectins Binds to parasitoid egg on same sites as host lectins preventing non‐self recognition of egg Function not determined, possible role in disruption of host larval growth and development Function not determined, possible role in disruption of host cellular immunity through interference with cell to cell signaling Possible role in epigentic Description Characterized by cysteine‐rich motifs and conserved exon and intron structures Share homology with cellular protein tyrosine phosphatases Homologous to invertebrate c‐type lectins Characterized by presence of highly conserved 540bp repeated sequence element High sequence homology with invertebrate innexin genes which encode for gap junction proteins High sequence homology with 10 Example: CpBV‐H4 host histone H4 genes modification of chromatin sturcture resulting in alteration of gene expression Inhibition of cellular immue response and downregulates gene expression of host H4 The Cys gene family is characterized by cysteine‐rich motifs and conserved exon and intron structures. Members of this gene family have been linked to suppression of host cellular immunity [36, 39]. An example is the VHv1.1 protein of CsIV which was found to bind to the surface of hemocytes, be internalized through endocytosis, and interfere with encapsulation by an unknown mechanism [39]. A role for VHv1.1 in the inhibition of cellular immunity was confirmed by the disruption of the encapsulation response against wasp eggs following in vivo expression of VHv1.1 from a recombinant baculovirus within the host larvae [76]. VHv1.1 has also been observed to disrupt host larval growth and development, possibly through inhibition of host protein synthesis [39]. This is supported by results in which translation of fat body mRNAs from larval hosts were reduced in the presence of recombinant VHv1.1 in vitro [72, 76]. Another PDV gene family is the protein tyrosine phosphatases, which have be linked to both up and down regulation of intracellular signaling through dephosphorylation of tyrosine residues on signaling molecules [31, 73]. The Microplitis demolitor BV gene ptp H2 encodes a protein tyrosine phosphatase that has been shown to both inhibit phagocytosis by plasmocytes and granulocytes [64]. ptpH2 is able induce apoptosis of these immune cells and is thought to act by interfering with the cell cycle [64]. 11 The C‐type lectin gene family is homologous to invertebrate c‐type lectins which act as pattern recognition molecules that can bind surfaces of foreign objects, opsonizing them for recognition by components of the cellular immune system [50]. It is thought that PDV c‐ type lectins are able to interfere with hemocyte biding to parasitoid eggs by competing with host lectins and ‘masking’ molecular patterns, thus preventing recognition by the host immune response [34, 55]. One PDV c‐type lectin, CpBV‐lectin, binds to the parasitoid egg on the same sites as host lectin but is not recognized by hemocytes and therefore prevents non‐self recognition of the parasitoid egg, resulting in the prevention of encapsulation [51]. The Rep gene family is characterized by the presence of a highly conserved 540bp repeated sequence element [26]. This gene family represents the largest PDV gene family identified thus far and is highly conserved among Ichnoviruses; however, the function of rep gene family members has not yet been determined [24, 36]. In a recent study, rep genes were found to be predominately expressed in the cuticular epithelium, nervous system and fat body cells of the lepidopteran host as opposed to within hemocytes [26]. This suggests that the rep genes, rather than playing a direct role in the suppression of the immune response may contribute to the disruption of the lepidopteran host larval growth and development [26]. Another PDV gene family, the vinnexin genes display high sequence homology with the invertebrate innexin genes which encode for gap junction proteins [26, 68]. Gap junctions are used for cell to cell communication to coordinate multicellular processes [68]. Although the exact role that vinnexins play is unclear it is thought that they may disrupt 12 host cellular immunity by interfering with cell to cell signaling between hemocytes during encapsulation resulting in an ineffective encapsulation response [68]. Another group of PDV genes found in some BV’s share high sequence similarity with host histone H4 [77]. In eukaryotic cells chromosomal DNA is wrapped around histone particles which are composed of two molecules of each H2A, H2B, H3 and H4 [77]. Chromatin structure can be modified by the action of histone actyltransferase and histone deacetylase which can modify the histone H4 amino‐terminal tails in order to increase or restrict access to DNA sequences therefore modulating gene expression [77]. An example of a PDV histone H4 gene is CpBV‐H4 [77]. When transiently expressed, CpBV‐H4 has been found to significantly impair the cellular immune response as well as suppress host H4 gene expression [77]. CpBV‐H4 is very similar to host H4 but posses an extend N‐terminal tail [77]. The removal of this N‐terminal tail abolishes the inhibition of cellular immunity and host H4 gene expression mediated by CpBV‐H4 [77]. These observations have lead to the hypothesis that viral H4 may alter chromatin structure through epigenetic modification, resulting in altered host gene expression [77]. Evolution of Polydnavirus Although much has been learned about the lifecycle and genes of PDVs, the questions of where they originated from and how they evolved their symbiotic relationship with parasitic wasps have remained unanswered [28]. There has been two main viewpoints on the evolution of PDVs; either they are the descendents of pathogenic insect viruses that have become fixed in a symbiotic relationship with parasitoid wasps or they 13 are a wasp derived genetic secretion system [18, 73] However, these two theories are not necessarily mutually exclusive [73]. Host‐range and structural similarities between PDVs and typical ‘free‐living’ viruses of their lepidopteran hosts suggests that PDVs evolved from insect viruses via the process of symbiogenesis [16,20] This is similar in theory to the acquisition of mitochondria and chloroplasts by eukaryotic cells from bacteria [16, 20]. Evidence supporting this hypothesis has recently been found for both Bracoviruses and Ichnoviruses [9, 10, 11]. Recently, a set of nudivirus related genes that are expressed in the ovaries of braconid wasps have been identified [10]. Nudiviruses are a diverse group of large, circular dsDNA viruses that are pathogenic for a wide range of invertebrates and are transmitted via feeding and/or mating routes [78]. Although there is little information available as to the function of nudivirus genes they do share a set of essential genes with another well characterized insect virus, baculovirus [10]. The nudivirus genes found to be expressed in the female wasp that are conserved in baculoviruses include genes that encode for subunits of viral RNA polymerase, proteins involved in particle assembly and packaging as well as envelope proteins [10]. However, no nudivirus related genes could be found packaged in viral particles [10]. A similar story for the Ichnovirus genera is also emerging [11]. Similarities between the structural proteins of Ichnovirus and typical ‘free‐ living’ insect viruses, ascoviruses, have been discovered which suggests that these PDVs also evolved from the integration of an insect virus [11]. Therefore a common evolutionary theory can be drawn up for both families of PDVs in which an ancestral virus became integrated within the wasp genome 70 to 100 million years ago [10, 11]. Viral genes not essential for parasitic survival in the lepidopteran host would be deleted from the packaged genome over time and replaced with wasp genes encoding for proteins that 14 enhanced parasitoid survival [11]. Although the exact mechanism of this evolution has not been discovered as of yet, it is clear that PDVs and parasitic wasps exemplify a novel symbiosis between virus and host and represent a very intriguing and expanding field of study. Endogenous Retroviruses Background While recent findings strongly suggest that PDVs evolved from typical ‘free‐living’ viruses of insects, it is accepted that endogenous retroviruses (ERVs) are derived from their exogenous counterparts. ERVs are the remnants of exogenous retroviruses that became integrated within the host genome in germ line cells and were subsequently passed down vertically within a species in a classical Mendelian fashion [57]. ERVs have been found to be present in all vertebrate genomes [41]. The continuous infection by retroviruses over the course of evolution has lead to the accumulation of large numbers of ERVs within the genomes of mammals and other vertebrates [32]. This is evident in the fact that ERVs make up approximately 8 and 10 percent of the human and murine genomes, respectively [27, 48]. The structure of the typical ERV provirus consists of the main retroviral structural genes gag, pro, pol and env which are flanked on both sides by long terminal repeats that were produced during reverse transcription [32]. Almost all retroviruses that have become endogenous are defective due to the accumulation of multiple deletions, mutations and/or stop codons and are therefore no longer able to produce infectious virus particles [29]. However, there are numerous ERVs that still contain intact open reading frames, most notably in the env gene, and thus remain to be 15 expressed [32]. In addition to possible roles in diseases, such as cancer and autoimmune disorders, it is likely that many ERVs have had some beneficial effect on their hosts over the course of evolution (14, 32, 41,). This is evident by their persistence in the face of selective pressures that would remove sequences harmful to survival of the host (14, 32, 41,). This section will focus on the beneficial roles ERVs play in their hosts, such as interfering with exogenous retroviruses at both pre‐ and post‐entry stages of the retroviral lifecycle (Figure2), as well as their possible roles in host physiology. Figure 2A: Retroviral lifecycle and blocks imposed by endogenous retrovirues. The initial step in retroviral infection, the binding of the retrovirus to its cellular receptor is blocked by several genes derived from endogenous retroviruses (ERVs) via receptor interference; Fv4 [40, 66, 67], Rmcf [34,70] and Rmcf2 [70] found in mice; enJSRV env of sheep [53,62]; ev3, ev6 and ev9 in chickens [60]; enFLV env in domestic cats and related feline species [41]; HERV‐ 16 W env derived from a human endogenous retrovirus protects permissive non‐ human cells in cell culture suggesting a possible protective role in humans [55] . Further along in the retroviral lifecycle the FV1 gene found in mice imposes a block following reverse transcription but prior to nuclear import possibly by binding to the viral capsid, preventing disassembly and formation of the pre‐ integration complex [1, 8, 75]. Two transdominant enJSRVs, enJSRV561A and enJSRV‐20 are capable of blocking the transport of JSRV virus particles to the cell surface for release [2, 3, 49, 58, 53]. The enJSRV gag protein is thought to bind to JSRV gag, disrupting its association with cellular endosomal transport machinery and leading to its subsequent degradation by cellular proteasomes [2, 3, 49, 50, 43, 55]. Figure adapted from reference [63]. Receptor Interference The block in entry of exogenous retroviruses by ERV components is one of the main symbiotic effects exhibited by ERVs and there are numerous examples of this protective effect. Endogenous Jaagsiekte sheep retrovirus (enJSRV) has been shown to block JSRV entry into ovine cells [62]. Jaagsiekte sheep retrovirus (JSRV) is an oncogenic betaretrovirus that is the causative agent of ovine adenocarcinoma, a transmissible cancer in sheep that is similar to human bronchiole‐alveolar carcinoma. [13, 54].The sheep genome contains approximately 27 endogenous Jaagsiekte sheep retrovirus (enJSRV) copies [2]. Five intact proviruses, enJSRV‐7,‐15,‐16,‐18 and ‐26, contain open reading frames (ORFs) for all the retroviral genes and share 85 to 89 percent nucleotide similarity to exogenous JSRV [53]. It is important to note that all enJSRVs lack a portion of the env gene that has been found to be critical for transformation in vitro [13]. In regards to blocking JSRV entry, the exogenous virus is observed to readily infect ovine cells which have no enJSRV expression while exhibiting a significantly reduced ability to enter cells that express high levels of enJSRV [53, 62]. This impairment in infectivity has also been seen in cell lines that were transfected with and stably express the enJSRV envelope 17 glycoprotein [53, 62]. These observations suggest that the mechanism of this block in entry may be through receptor interference [52]. This mechanism of resistance to JSRV is further supported by the fact that both exogenous JSRV and enJSRV envelope glycoprotein bind the same cellular receptor, hyaluronidase‐2 [62]. Receptor interference may occur through either enJSRV env saturating the cellular receptor or by limiting its surface expression [53]. In either case this results in the reduced accessibility of this receptor to exogenous JSRV [53]. Figure 2B: Receptor interference in mice. The Fv4, Rmcf and Rmcf2 genes are derived from ecotropic, polytropic or xenotropic stains of MLV, respectively, and encode for envelope glycoproteins [40, 34, 66, 67, 70]. These Fv4, Rmcf and Rmcf2 encoded glycoproteins can bind the CAT‐1, Xpr1 or Xpr1Sxv receptors, respectively. It is believed that these ERV encoded glycoproteins associate with the receptors in the ER, preventing processing and transport to the cell surface. 18 This results in an entry block against exogenous ecotropic strains of MLV in the case of Fv4 and exogenous polytropic strains of MLV in the case of Rmcf and Rmcf2. There are also three genes, Fv4, Rmcf and Rmcf2, derived from ERVs, found in the genomes of mice that are participate in receptor interference against murine gamma retroviruses [40 34, 70] (Figure 2B). The Fv4 gene locus has been found to provide resistance to infection caused by ecotropic strains of murine leukemia virus (MLV) [40]. Ecotropic strains are defined as MLVs that preferentially replicate in murine cells [80]. The Fv4 locus was determined to be a defective ERV that contains the 3’ end of the pol gene and a complete env gene that expresses a MLV like envelope glycoprotein [67]. The Fv4 env gene product shares approximately 70 percent amino acid sequence similarity with ecotropic moloney MLV and friend MLV [67]. This Fv‐4 env has been shown to be capable of binding the ecotropic MLV receptor, CAT‐1, resulting in the inhibition of entry to these cells by MLV via receptor interference [67]. The entry block is not absolute and depends on the level of Fv‐4 expression [67]. In the event that an exogenous virus escapes this block in entry and infects the cell, the resulting virus particles will have diminished infectivity [67]. This is due to incorporation of the Fv4 encoded envelope protein that contains a mutation in the fusion peptide of its transmembrane domain that is required for entry [67]. Found in the genome of DBA/2J mice, the Rmcf gene is similar to the Fv4 gene in that it is made up of an incomplete pol and an intact env gene that belongs to an endogenous polytropic MLV (P‐MLV) [34]. Polytropic MLVs arise in mice through the recombination of ecotropic MLVs with endogenous retroviral envelope genes [81]. The Rmcf gene product interferes with exogenous P‐MLV entry though binding of Xpr1 receptor that P‐MLV uses for entry [34]. 19 Another mouse gene similar to Rmcf, Rmcf2, is also capable of blocking retroviral entry through receptor interference [70]. Rmcf2 also blocks P‐MLVs but is composed of an endogenous xenotropic MLV (X‐MLV) [70]. Xenotropic MLVs are characterized by limited replication in murine cells but replicate well in cells from other species [80]. This endogenous X‐MLV, unlike FV4 and Rmcf does not contain deletions in the retroviral genes but cannot form infectious virus due to a stop codon in the integrase gene [70]. The blocking of P‐MLVs by the endogenous X‐MLV of Rmcf2 can only occur in mice with the Xpr1Sxv receptor variant, found in many wild mouse species, that permits infections by both P‐MLVs and X‐MLVs [70]. These three murine ERV encoded glycoproteins are believed to associate with their receptors in the endoplasmic reticulum, preventing processing and transport to the cell surface [63]. Resistance to exogenous retroviral infection through receptor interference by ERVs has also been long observed in chicken and cats [32]. In chickens, three defective endogenous avian leukosis viruses (ALVs), ev3, ev6 and ev9, express high levels of ALV subgroup E like env glycoproteins [60]. Expression of these glycoproteins reduces the susceptibility of chickens to ALV subgroup E infections via receptor interference [60]. In domestic cats and related feline species, defective endogenous feline leukaemia virus (FeLV) related sequences are found in 8‐12 copies per cell [46]. These sequences encode for a truncated env gene product that is shed from the cells and is responsible for resistance to infection by FeLV subgroup B through a receptor interference mechanism [46]. 20 Also of interest in terms of receptor interference is a human endogenous retrovirus (HERV), HERV‐W, which exists in an estimated 30 to 100 copies in the human genome [55]. HERV‐W has recently been show to induce cellular resistance to the gamma retrovirus spleen necrosis virus (SNV) in vitro [55]. When the HERV‐W env gene was stably expressed in a canine osteosarcoma cell line, which is normally permissive for SNV, a decrease in SNV infection up to 10,000 fold was observed compared to control cell lines [51]. It has also been recently shown that both HERV‐W env and SNV bind the same receptor, RDR, a sodium‐dependent neutral amino acid transporter [55].This suggest that the observed resistance is due to receptor interference [55]. Although the biological relevance of this resistance is unclear it may explain the resistance of human cells to SNV infection despite the expression of RDR in many human tissues [55]. PostEntry Blocks In addition to protecting host cells from retroviral infection by blocking viral entry, a number of ERVs are also capable of interfering with other steps of the retroviral lifecycle (Figure 2). EnJSRVs, in addition to being able to block exogenous virus via receptor interference, have also been shown to block exogenous JSRV at a later stage during retroviral infection [49]. Two enJSRVs, enJSRV561A and enJSRV‐20, have been shown to inhibit virus production from JSRV infected cells [3]. These ERVs possess intact ORFs for all viral genes (gag, pro, pol, env) except for orf‐x, which has unknown function, due to the presence of a premature stop codon [53]. This transdominant effect of these two enJSRVs has been mapped to the amino acid at position 21 of the enJSRV gag polyprotein [50]. In 21 exogenous JSRV and all other beta retroviruses this position contains a conserved arginine (R21) residue however, in the transdominant enJSRV this position is occupied by a tryptophan residue (W21) [2, 50]. The enJSRV56A1 gag protein is able to interact with exogenous JSRV gag protein soon after synthesis and disrupt its pericentriolar cellular localization [50]. Beta retroviruses such as JSRV are thought to assemble in the pericentriolar region of the cytoplasm and utilize the cellular endosomal trafficking machinery in order to transport the viral particles to the cellular membrane for release [3, 50] This is unlike other retroviruses that assemble at the cell membrane prior to release as is observed for HIV [50]. Although the precise mechanism of this transdominant effect is not known, it is thought that JSRV and enJSRV gag co‐assemble, resulting in the disruption of the interaction between JSRV gag and the endosomal trafficking machinery [49,50] This is expected to inhibit viral transport to the cell surface [49,50]. The enJSRV gag protein is thought to behave like a misfolded protein due to the tryptophan residue at position 21, which is hydrophobic in a region normally exposed in JSRV gag [50]. This leads to the accumulation of chimeric viral particles within aggresomes and their subsequent degradation by the cellular proteasomes [50]. It is of interest to note that in a recent study an enJSRV which likely integrated within the last 200 years, enJSRV‐26, was found to escape this restriction by transdominant enJSRV when expressed in a transient transfection assay [4]. This finding suggests that there are ongoing counter‐adaptations occurring between endogenous and exogenous JSRV [4]. In this relationship enJSRVs that protect against JSRV are positively selected for and that JSRV can evolve mechanisms to evade this resistance [4]. 22 ERV mediated resistance to retroviral infection due to post‐entry blocks in the retroviral lifecycle are also seen in mice (Figure 2). The Fv1 gene has been found to provide resistance against ecotropic strains of MLV [8, 75]. Although this restriction is not absolute it has been observed to reduce viral titers by 50 to 1000 fold in vitro [8, 75]. The Fv1 gene is derived from the gag region of the MuERV‐L family of endogenous retroviruses, a family of ERVs that is unrelated to MLV, and encodes a retroviral capsid‐like protein [8, 75]. There are two main alleles of FV1, Fv1n and Fv1b that facilitate the division of ecotropic MLVs into N‐tropic and B‐tropic viruses [65, 82]. The Fv1n allele, found in NIH Swiss mice, provides resistance to B‐tropic MLVs but remains susceptible to N‐tropic MLVs [83]. This is in contrast to the Fv1b allele, found in BALB/c mice, which shows the reciprocal pattern of resistance/susceptibility [1, 83]. A third allele, Fv1nr, restricts B‐tropic MLVs and some, but not all, N‐tropic MLVs [83]. Fv1nr is found in various inbred strains of mice and possibly some wild mice [83]. N‐tropic MLVs that are restricted by Fv1nr are referred to as NR‐tropic [83]. A fourth allele of FV1, Fv1null allele does not provide resistance to any subgroup of MLVs [1]. Although the mechanism of this resistance remains to be determined it has been deduced that the Fv1 gene product targets the viral capsid protein to block the retroviral lifecycle after reverse transcription of the viral genome but prior to nuclear import and integration [75]. One possible mechanism is that the Fv1 encoded capsid‐like proteins interact with the exogenous virus capsid, interfering with capsid disassembly and formation of the pre‐integration complex thus preventing integration and virus production [75]. 23 Roles in Host Physiology ERVs, in addition to interfering with exogenous retrovirus infection may also play essential roles in host physiology. In humans, two ERV env proteins Syncytin‐1 and Syncytin‐2 which are derived from HERV‐W and HERV‐FRD, respectively have been implicated in the process of placenta morphogenesis [21]. The placenta is a complex structure that permits diffusion between fetal and maternal circulatory systems [45]. During the development of the placenta, a crucial process involves the differentiation and fusion of fetal trophoblast cells which results in the formation of the syncytial trophoblast [45] This multinucleated layer erodes a path in the uterine epithelium during implantation [45]. The syncytial trophoblast layer makes up the boundary between fetal and maternal compartments of the placenta [42]. The molecular mechanisms involved in this process are not that well understood, however, a role for syncytin‐1 and syncytin‐2 in this process is suggested [42]. This is supported by the fact that the two syncytins have been shown to be fusogenic, able to induce cell‐cell fusion, ex vivo and are specifically expressed at the trophoblast‐syncytial trophoblast interface within the placenta [42]. Additionally, the receptors for syncytin‐1 and syncytin‐2, RDR, an amino acid transporter and major facilitator superfamily domain containing 2, a presumptive carbohydrate transporter, are expressed at relatively high levels in the placenta [21]. The role of the syncytins in human placenta morphogenesis requires more intense study but it is appears that these ERV proteins are involved and may be essential to this process. Two ERV env genes that behave in a similar fashion to human syncytin‐1 and syncytin‐2, but are phylogenetically unrelated, have been identified in the murine genome, syncytin‐A and syncytin‐B [19]. Much like the 24 human syncytins, the murine syncytins have been shown to be specifically expressed in the placenta within the syncytial trophoblast and are highly fusogenic in vitro [19] Another role of ERV env proteins in host physiology is suggested by the fact that many exogenous retroviral envelope proteins can suppress host immune responses [37]. This is due to the presence of a highly conserved immunosuppressive domain [37]. Recently, it has been demonstrated that in both human and mice one of the syncytin proteins, syncitin‐2 in humans and syncytin‐B in mice, possess immunosuppressive properties [42]. This was demonstrated by the ability of injected syncytin expressing tumor cells to develop into large tumors that persisted in immunocompetent allogeneic mice [42]. In contrast these mice cleared such tumors in the absence of syncytin expression in an immune mediated fashion [42]. Other HERVs displaying this same immunosuppressive effect include HERV‐H and ERV‐3 [32, 37]. While this suggests that ERVs may play a role in cancer progression and persistence it also raises the idea that immunosuppressive ERV proteins expressed in the placenta may have beneficial effects [32, 37]. ERV mediated immunosuppression could play a key role in protecting the developing fetus from attack by the maternal immune system, thus preventing rejection of the developing fetus [32, 37]. Supporting the theory that syncytins are important in placenta development in humans and mice, it has been shown that enJSRVs env expression is essential to placenta morphogenesis in sheep [17]. EnJSRVs are highly expressed in the female reproductive tract with expression concentrated in the trophoblast giant binucleate cells and multinucleated syncytia [17]. These structures form from the fusion of trophoblast cells and make up the placentomes, which are analogous to the placenta in humans [17]. The 25 receptor for the enJSRV envelope glycoprotein, HYAL2, is also highly expressed in these tissues, suggesting a fusogenic role in placenta morphogenesis as proposed for the syncytins. [2] In a 2006 study by Spencer et al. expression of enJSRV env mRNAs in the reproductive tract of pregnant sheep was inhibited by use of morpholino antisense oligonucleotides (MAO) to study the biological relevance of this enJSRV expression [17]. The injection of enJSRV env specific MAO resulted in the development of fetuses that were fragile, smaller and contained fewer trophoblast giant binucleate cells compared to control animals [17]. This disruption in conceptus formation was then followed by pregnancy loss in nearly all of the sheep that received enJSRV env MAOs [17]. This study proved that enJSRV has an essential biological role in placenta morphogenesis and the establishment of pregnancy in sheep. In addition, this discovery has added to the body of evidence that suggests ERVs may play essential roles in placenta formation and perhaps other physiological processes in other vertebrates. Other symbiotic viruses In addition to PDVs and ERVs there are also a number of other viruses that have been found to have a beneficial effect on their hosts. A recent study by Barton et al. has raised the issue as to whether latent herpes virus infections may have a symbiotic effect by modulating the host’s innate immune system [6]. This immune modulation may help protect the host from potentially life threatening infections [6]. In this study mice latently infected with gamma herpes 68, which is genetically similar to Epstein‐Barr virus, or murine cytomegalovirus, which is similar to human cytomegalovirus, were challenged with 26 Listeria monocytogenes and Yersinia pestis, the causative agent of the plague [6]. In both cases latently infect mice exhibited a significant reduction in bacterial replication and systemic spread as compared to control mice without a latent herpes infection [6]. This protection was correlated with higher levels of serum IFN‐γ and TNF‐α as well as higher levels of macrophage activation present in latently infected mice [6]. However, this protective effect did not apply to all pathogens as West Nile virus infection preceded the same in the presence or absence of latent herpes infection [6]. The authors propose a cross‐ protective mechanism in which latent viral infection results in the chronic presentation of small amounts of viral antigens during reactivation [6]. This results in chronic T‐cell activation and IFN‐y secretion that protects the host from other pathogens by activating the innate immune system, particularly macrophages [6]. This issue has not been studied in humans but due to the genetic similarity between these pathogens of mice and those of humans it is plausible that herpes viruses may also have a similar beneficial role in humans [6]. However, in a follow up study by Blackman et al. it was found that this symbiotic protective effect failed to persist with life long viral latency in infected mice [79]. Protection from bacterial infections was found to be transit, lasting as long as 5 months while the elevated serum levels of IFN‐γ and TNF‐α were undetectable after 2 months [79]. Another study that suggests a role for herpes virus in the modulation of the immune system investigated wheatear the infectious burden of children was associated with IgE sensitization to environmental antigens [52]. In this study the authors identified EBV and CMV infection as playing a role in the level of IgE sensitization [52]. It was found that the risk of IgE sensitization was reduced in children that were infected with EBV by age two and this effect was increased with cytomegalovirus co‐infection [52]. These studies 27 strongly suggest a role of herpes viruses in shaping the immune response, both in terms of pathogen resistance and the development of allergies. These observations also raise the question as to whether other common viral infections may have beneficial immune modulating effects. Symbiotic viruses are also seen in fugal‐plant associations where the interaction can become very complex. An interesting example is seen in the symbiotic relationship between the tropical panic grass, Dichanthelium lanuginosum and the fungus Curvularia protuberate [44]. Studies have shown that when associated with the fungus, the plant can grow in soil temperatures up to 65°C whereas non‐fungus associated plants cannot grow at temps above 38°C [44]. This heat‐resistance effect was found to be dependent on the presence of a RNA virus found within the fungus referred to as CThTV [44]. It was proposed that the virus interferes with the induction of the stress response pathway in the plants resulting in a decrease in the production of reactive oxygen species that are potentially damaging to the plant [44]. Concluding Remarks As this review has demonstrated not all eukaryotic viruses have detrimental or benign effects on the hosts they infect but in fact there are numerous examples of viral infections that have beneficial effects on their hosts. Two main themes as to how these symbiotic viruses benefit their hosts have emerged in this review; the first being a result of lateral gene transfer via integration and secondly though modulation of the immune system. In the case of lateral gene transfer, it has been shown that a number of ERVs have provided 28 their hosts with new genetic material that is capable of being expressed. Some of these ERV derived proteins are able to protect against retroviral infection and others may play essential roles in host physiology. Also following this theme, ancestral PDVs that infected parasitic wasps millions of years ago have provided these wasps with the ability to package and transfer immunosuppressive genes that ensure the survival and development of their offspring within a lepidopteran host. The process of acquiring new functions through a symbiotic relationship with a virus is comparable to the endosymbiotic theory that describes the acquisition of the chloroplast and mitochondria by the ancestral eukaryotic cells from bacteria [23]. These discoveries suggest that it is likely that other components of host physiology within many species have been acquired though the process of symbiotic relationships with viruses. Support for this comes from the fact that the genomes of many species are composed of large amount of ERV sequences. This introduced genetic material has the potential to encode for functions that would take millions of years longer to develop though simple Darwinian evolution allowing for more rapid evolution [43] This theory was popularized by Lynn Margulis who suggested that symbiotic relationship are the driving force of evolution [43] . The second theme, immune modulation, suggests that numerous viral infections may play important roles in shaping the immune responses of their hosts. Viral mediated immune modulation may protect the host against potentially life threatening illness and in turn increase the chance of survival. This was seen in the studies that showed an apparent role of latent herpes viruses in protecting their hosts from infection by L. monocytogenes and Y. pestis Listeria through a heightened state of innate immune activation, as well as the possible role of EBV modulating the development of allergies [6, 52]. This effect has also been observed in plants in which a fungal virus 29 appears to prevent damage to the plant in response to high temperatures through a reduction in a potentially destructive stress response [44]. From this review it is apparent that viruses are capable of more than they are generally given credit for. With roles in pathogen resistance, immune modulation and host physiology, viruses have potentially played an important role in the evolution of eukaryotic life. The symbiotic virus host relationships discovered so far are likely just the tip of the ice berg and represent an intriguing and expanding area of virology. References 1. Aagaard, L., J. G. Mikkelsen, S. Warming, M. Duch, and F. S. Pedersen. 2002. Fv1‐like restriction of N‐tropic replication‐competent murine leukemia viruses in mCAT‐1‐ expressing human cells. J Gen Virol. 83: 439‐442. 2. Arnaud, F., M. Varela, T. E. Spencer, and M. Palmarini. 2008. Coevolution of endogenous betaretroviruses of sheep and their host. Cell Mol Life Sci. 65: 3422‐3432. 3. Arnaud, F., P. R. Murcia, and M. Palmarini. 2007. Mechanisms of late restriction induced by an endogenous retrovirus. J Virol. 81: 11441‐11451. 4. Arnaud, F., M. Caporale, M. Varela, R. Biek, B. Chessa, A. Alberti, M. Golder, M. Mura, Y. Zhang, L. Yu, F. Pereira, J. DeMartini, K. Leymaster, T. Spencer, and M. Palmarini. 2007. A paradigm for virus‐host coevolution: sequential counter‐adaptations between endogenous and exogenous retroviruses. PLoS Path. 3: 1716‐1726. 5. Asgari, S., O. Schmidt, and U. Theopold. 1997. A polydnavirus‐encoded protein of an endoparasitoid wasp is an immune suppressor. J Gen Virol. 78: 3061‐3070. 6. Barton, E. S., D. W. White, J. S. Cathelyn, K. A. Brett‐McClellan, M. Engle, M. S. Diamond, V. L. Miller, and H. W. Virgin. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 447: 326‐329. 7. Beck, M. H., R. B. Inman, and M. R. Strand. 2007. Microplitis demolitor bracovirus genome segments vary in abundance and are individually packaged in virions. Virol. 359: 179‐189. 8. Best, S., P. Le Tissier, G. Towers, and J. P. Stoye. 1996. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature. 382(6594):826‐9 30 9. Bezier, A., J. Herbiniere, C. Serbielle, J. Lesobre, P. Wincker, E. Huguet, and J. Drezen. 2008. Bracovirus gene products are highly divergent from insect proteins. Arch Insect Biochem. 67: 172‐187. 10. Bezier, A., M. Annaheim, J. Herbiniere, C. Wetterwald, G. Gyapay, S. Bernard‐Samain, P. Wincker, I. Roditi, M. Heller, M. Belghazi, R. Pfister‐Wilhem, G. Periquet, C. Dupuy, E. Huguet, A. Volkoff, B. Lanzrein, and J. Drezen. 2008. Polydnaviruses of braconid wasps derive from an ancestral nudivirus. Science. 323(5916):926‐30 11. Bigot, Y., S. Samain, C. Auge‐Gouillou, and B. A. Federici. 2008. Molecular evidence for the evolution of ichnoviruses from ascoviruses by symbiogenesis. BMC Evol Biol. 8: 253. 12. Blond, J., D. Lavillette, V. Cheynet, O. Bouton, G. Oriol, S. Chapel‐Fernandes, B. Mandrand, F. Mallet, and F. Cosset. 2000. An envelope glycoprotein of the human endogenous retrovirus HERV‐W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol. 74: 3321‐3329. 13. Caporate, M., C. Cousens, P. Centorame, C. Pinoni, M. De las Heras, and M. Palmarini. 2006. Expression of the jaagsiekte sheep retrovirus envelope glycoprotein is sufficient to induce lung tumors in sheep. J Virol. 80: 8030‐8037. 14. Christensen, T. 2005. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes virus. Rev. Med. Virol. 15(3):179‐211 15. Denesvre, C., D. Soubieux, G. Pin, D. Hue, and G. Dambrine. 2003. Interference between avian endogenous ev/J 4.1 and exogenous ALV‐J retrovirus envelopes. J Gen Virol. 84: 3233‐3238. 16. Drezen, J. M., B. Provost, E. Espagne, L. Cattolico, C. Dupuy, M. Poirie, G. Periquet, and E. Huguet. 2003. Polydnavirus genome : integrated vs. free virus. J Insect Physiol. 49: 407‐417. 17. Dunlap, K. A., M. Palmarini, M. Varela, R. C. Burghardt, K. Hayashi, J. L. Farmer, and T. E. Spencer. 2006. Endogenous retroviruses regulate periimplantation placental growth and differentiation. PNAS. 103: 14390‐14395. 18. Dupuy, C., E. Huguet, and J. Drezen. 2006. Unfolding the evolutionary story of polydnaviruses. Virus Res. 117: 81‐89. 19.Dupressoir, A., G. Marceau, C. Vernochet, L. Benit, C. Kanellopoulos, V. Sapin, and T. Heidmann. 2005. Syncytin‐A and syncytins‐B, two fusogenic placenta‐specific murine envelope genes of retroviral origin conserved in Muridae. PNAS. 102: 725‐730. 20. Edson, K.M, Vinson, S.B., Stoltz, D.B. and Summers, M.D. 1981. Virus in a parasitoid wasp: suppression of the cellular immune response in the parasitoids host. Science 211(4482):582 31 21.Esnault, C., S. Priet, D. Ribet, C. Vernochet, T. Bruis, C. Lavialle, J. Weissenbach, and T. Heidmann. 2008. A placental‐specific receptor for the fusogenic, endogenous retrovirus‐ derived, human syncytins‐2. PNAS. 105: 17532‐17537 22. Fath‐Goodin, A., T. A. Gill, S. B. Martin, and B. A. Webb. 2006. Effect of Campoletis sonorensis ichnovirus cys‐motif proteins on Heliothis virescens larval development. J Insect Physiol. 52: 576‐585. 23. Federici, B. A., and Y. Bigot. 2003. Origin and evolution of polydnaviruses by symbiogenesis of insect DNA viruses in endoparasitic wasps. J Insect Physiol. 49: 419‐432. 24. Fleming J‐A, Krell PJ. 1993. Polydnavirus genome organization. Parasites. 1:189–225 25. Fleming, J.G.W., and Summers M.D. 1986. Campoletis sonorensis endoparasitic wasps contain forms of C.sonorensis virus DNA suggestive of integrated and extrachromosomal polydnavirus DNAs. Virol J.57:552‐562 26. Galibert, I., G. Devauchelle, F. Cousserans, J. Rocher, P. Cerutti, M. Barat‐Houari, P. Fournier, and A. N. Volkoff. 2006. Members of the Hyposoter didymator ichnovirus repeat element gene family are differentially expressed in Spodoptera frugiperda. Virol J. 3:48 27. Genome international sequencing consortium. 2001. Initial sequencing and analysis of the human genome. Nature. 409:860‐921 28. Glatz, R. V., S. Asgari, and O. Schmidt. 2004. Evolution of polydnaviruses as insect immune suppressors. Trends Microbiol. 12: 545‐554. 29. Griffiths, P. D. 2004. From restriction factors to restriction enzymes. Rev Med Virol. 14: 1‐2. 30. Gullan, P. J., and P. S. Cranston. 2005. The insects: an outline of entomology. Oxford: Blackwell Publishing. 3: 75‐77. 31. Ibrahim, A. M., and Y. Kim. 2008. Transient expression of protein tyrosine phosphatases encoded in Cotesia plutellae bracovirus inhibits insect cellular immune responses. Naturwissenschaften. 95: 25‐32. 32. Jern, P., and J. M. Coffin. 2008. Effects of retroviruses on host genome function. Annu Rev Genet. 42: 709‐732. 33. Jiu, M., X. Zhou, L. Tong, J. Xu, X. Yang, F. Wan, and S. Liu. 2007. Vector‐virus mutualism accelerates population increase if an invasive whitefly. PLoS One 2(1):e182 34. Jung, Y. T., M. Soo Lyu, A. Buckler‐White, and C. A. Kozak. 2002. Characterization of a polytropic murine leukemia virus proviral sequence associated with the virus resistance gene Rmcf of DBA/2 mice. J Virol. 76: 8218‐8224. 32 35. Kim, Y., J. Young Choi, and Y. Ho Je. 2007. Cotesia plutellae bracovirus genome and its function in altering insect physiology. J Asia‐Pacific Entomol. 10: 181‐191. 36. Kroemer, J. A., and B. A. Webb. 2004. Ploydnavirus genes and genomes: emerging gene families and new insights into polydnavirus replication. Annu Rev Entomol. 49: 431‐456. 37. Krell, P.J., 1980. Virus‐like particles in the ovary of an ichneumonid wasp‐purification and pereliminary characterization. J. Virol. 101:408 38. Lapointe, R., K. Tanaka, W. E. Barney, J. B. Whitfield, J. C. Banks, C. Beliveau, D. Stoltz, B. A. Webb, and M. Cusson. 2007. Genomic and morphological features of a banchine polydnavirus: comparison with bracoviruses and ichnoviruses. J Virol. 81: 6491‐6501. 39. Li, X., and B. A. Webb. 1994. Apparent functional role for a cysteine‐rich polydnavirus protein in suppression of the insect cellular immune response. J Virol. 68: 7482‐7489. 40. Limjoco, T. I., P. Dickie, H. Ikeda, and J. Silver. 1993. Transgenic Fv‐4 mice resistant to friend virus. J Virol. 67: 4163‐4168. 41. Mangeney, M., N. de Parseval, G. Thomas, and T. Heidmann. 2001. The full‐length envelope of an HERV‐H human endogenous retrovirus has immunosuppressive properties. J Gen Virol. 82: 2515‐2518. 42. Mangeney, M., M. Renard, G. Schlecht‐Louf, I. Bouallaga, O. Heidmann, C. Letzelter, A. Richaud, B. Ducos, and T. Heidmann. 2007. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. PNAS. 104: 20534‐20539. 43. Margulis, L. and Fester, R., 1991. Symbiosis as a Source of Evolutionary Innovation. , MIT Press, Cambridge, Massachusetts. 44. Marquez, L. M., R. S. Redman, R. J. Rodriguez, and M. J. Roossinck. 2007. A virus in a fungus in a plant: three‐way symbiosis required for thermal tolerance. Science. 315: 513‐ 515. 45. Martini, F. H., M. J. Timmons, and R. B. Tallitsch. 2006. Human anatomy. San Francisco: Pearson Education. 5: 750‐751. 46. McDougall, A. S., A. Terry, T. Tzavaras, C. Cheney, J. Rojko, and J. C. Neil. 1994. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol. 68: 2151‐2160. 33 47. Motuza, G. B., D. C. Goldstone, C. Pashley, L. F. Haire, M. Palmarini, W. R. Taylor, J. P. Stoye, and I. A. Taylor. 2009. Structure of the capsid amino‐terminal domain from the betaretrovirus, Jaagsiekte sheep retrovirus. J Mol Biol. 386: 1179‐1192. 48. Mouse genome sequencing consortium. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature. 420(6915):520‐62 49. Mura, M., P. Murcia, M. Caporale, T. E. Spencer, K. Nagashima, A. Rein, and M. Palmarini. 2004. Late viral interference induced by transdominant Gag of an endogenous retrovirus. PNAS. 101: 11117‐11122. 50. Murcia, P. R., F. Arnaud, and M. Palmarini. 2007. The transdominant endogenous retrovirus enJS56A1 associates with and blocks intracellular trafficking of jaagsiekte sheep retrovirus Gag. J Virol. 81: 1762‐1772. 51. Nalini, M., J. Young Choi, Y. Ho Je, I. Hwang, and Y. Kim. 2008. Immunoevasive property of a polydnaviral product, CpBV‐lectin, protects the parasitoid egg from hemocytic encapsulation of Plutella xylostella (Lepidoptera: Yponomeutidae). J Insect Physiol. 54: 1125‐1131. 52. Nilsson, C., A. Linde, S. M. Montgomery, L. Gustafsson, P. Nasman, M. Troye Blomberg, and G. Lilja. 2005. Does early EBV infection protect against IgE sensitization? J Allergy Clin Immunol. 116: 438‐444. 53. Palmarini, M., M. Mura, and T. E. Spencer. 2004. Endogenous bataretroviruses of sheep: teaching new lessons in retroviral interference and adaptation. J Gen Virol. 85: 1‐13. 54. Palmarini, M., J. M. Sharp, M. De las Heras, and H. Fan. 1999. Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep. J Virol. 73: 6964‐ 6972. 55. Ponferrada, V.G., B. S. Mauck, and D. P. Wooley. 2003. The envelope glycoprotein of human endogenous retrovirus HERV‐W induces cellular resistance to spleen necrosis virus. Arch Virol. 148: 659‐675. 56. Prudhomme, S., B. Bonnaud, and F. Mallet. 2005. Endogenous retroviruses and animal reproduction. Cytogenet Genome Res. 110: 353‐364. 57.Rasmussen, H. B. 1997. Interactions between exogenous and endogenous retroviruses. J Biomed Sci. 4: 1‐8. 58. Ravanfar P, Satyaprakash A, Creed R, and Mendoza N. 2009. Existing antiviral vaccines. Dermatol Ther. 22(2):110‐28 34 59. Richman A, Kafatos FC. 1996. Immunity to eukaryotic parasites in vector insects. Curr Opin Immunol. 8: 14‐19. 60. Robinson, H. L., S. M. Astrin, A. M. Senior, and F. H. Salazar. 1981. Host susceptibility to endogenous viruses: defective, glycoprotein‐expressing proviruses interfere with infections. J Virol. 40: 745‐751. 61.Schmidt, O., U. Theopold, and M. Strand. 2001. Innate immunity and its evasion and suppression by hymenopteran endoparasitoids. BioEssays. 23: 344‐351. 62. Spencer, T. E., M. Mura, C. A. Gray, P. J. Griebel, and M. Palmarini. 2003. Receptor usage and fetal expression of ovine endogenous betaretroviruses: implications for coevolution of endogenous and exogenous retroviruses. J Virol. 77: 749‐753. 63. Stocking, C., and C. A. Kozak. 2008. Murine endogenous retroviruses. Cell Mol Life Sci. 65: 3383‐3398. 64.Suderman, R. J., A. J. Pruijssers, and M. R. Strand. 2008. Protein tyrosine phosphatase‐H2 from a polydnavirus induces apoptosis of insect cells. J Gen Virol. 89: 1411‐1420. 65. T ailor, C. S., A. Nouri, C. G. Lee, C. Kozak, and D. Kabat. 1999. Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci. 96: 927‐932. 66. Takeda, A., and T. Matano. 2007. Inhibition of infectious murine leukemia virus production by Fv‐4 env gene products exerting dominant negative effect on viral envelope glycoprotein. Microbes Infect. 9: 1590‐1596. 67. Taylor, G. M., Y.Gao, and D. Avram Sanders. 2001. Fv‐4: identification of the defect in env and the mechanism of resistance to ecotropic murine leukemia virus. J Virol. 75: 11244‐ 11248. 68. Turnbull, M. W., A. Volkoff, B. A. Webb, and P. Phelan. 2005 . Functional gap junction genes are encoded by insect viruses. Curr Biol. 15(13):R492‐2 69. Vilmos, P., and E. Kurcuz. 1998. Insect immunity: evolutionary roots of the mammalian innate immune system. Immunol Lett. 62: 59‐66. 70. Wu, T., Y. Yan and C. A. Kozak. 2005. Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses. J Virol. 79: 9677‐9684. 71. Webb, B. A., and L. Cui. 1998. Relationships between polydnavirus genomes and viral gene expression. J Insect Physiol. 44: 785‐793. 35 72. Webb, B. A., M. R. Strand, S. E. Dickey, M. H. Beck, R. S. Hilgarth, W. E. Barney, K. Kadash, J. A. Kroemer, K. G. Lindstrom, W. Rattanadechakul, K. S. Shelby, H. Thoetkiattikul, M. W. Turnbull, and R. A. Witherell. 2006. Polydnavirus genomes reflect their dual roles as mutualists and pathogens. Virol. 347: 160‐174. 73. Webb, B. A., M. R. Strand. 2005 The biology and genomics of polydnaviruses. In: LI. Gilbert, K. Iatrou and SS. Gill, Editors, Comprehensive Molecular Insect Science, Elsevier ed, San Diego (2005), pp. 323–360. 74. Whitfield, J. B., and S. Asgari. 2003. Virus or not? Phylogenetics of polydnaviruses and their wasp carriers. J Insect Physiol. 49: 397‐405. 75. Yan, Y., A. Buckler‐White, K. Wollenberg, and C. A. Kozak. 2009. Origin, antiviral function and evidence for positive selection of the gammaretrovirus restriction gene Fv1 in the genus Mus. PNAS. 106: 3259‐3263. 76. Fath-Goodin, A., T. A. Gill, S. B. Martin and B. A. Webb. 2006. Effect of Campoletis sonorensis Ichnovirus cys-motif proteins on Heliothis virescens larval development. J. Insect. Physiol. 52: 576-585. 77. Gad, W. and Y. Kim. 2009. N-terminal tail of a viral histone H4 encoded in Cotesia plutellae bracovirus is essential to suppress gene expression of host histone H4. Insect. Mol. Biol. 18: 111118. 78. Wang, Y. and J. A. Jehle. 2009. Nudiviruses and other large, double-stranded circular DNA viruses of invertebrates: new insights on an old topic. J. Invertebr. Pathol. 101: 187-193. 79. Yager, E. J., F. M. Szaba, L. W. Kummer, K. G. Lanzer, C. E. Burkurn, S. T. Smiley and M. A. Blackman. 2009. γ–herpesvirus-induced protection against bacterial infection is transient. Viral Immunol. 22: 67-71. 80. Oie, H. K., A. F. Gazdar, P. A. Lalley, E. K. Russell, J. D. Minna, J. Delarco, G. J. Todaro and U. Francke. 1978. Mouse chromosome 5 codes for ecotropic murine leukaemia virus cell surface receptor. Nature. 274: 60-62 81. Lavignon, M., J.L. Walker, S.M. Perryman, F.G. Malik, A.S. Khan, T.S.Theodore and L.H. Evans. 1994. Characterization of epitopes defining two major subclasses of polytropic murine leukemia viruses (MuLVs) which are differentially expressed in mice infected with different ecotropic MuLVs. J. Virol. 68: 5194-5203 82. Besnier, C., L. Ylinen, B. Strange, A. Lister, Y. Takeuchi, S. P. Goff and G. J. Towers. 2003. Characterization of murine leukemia virus restriction in mammals. J. Virol. 77: 13403-13406. 36 83. Stevens, A., M. Bock, S. Ellis, P. LeTissier, K. N. Bishop, M. W. Yap, W. Taylor and J. P. Stoye. 2004. Retroviral capsid determinants of Fv1 NB and NR tropism. J. Virol. 78: 9592-9598. 37